4 ms·

Astra Zeneca bungled their FDA trials in 2020. They went from being one of the most promising vaccines to an also-ran. https://www.nytimes.com/2020/12/08/busi

• mchusma 6y ago
  This is basically a hit piece, and this type of journalism really hurts us because it misses the big picture. The reality is that Astrazeca ran full trials which proved safety and efficacy in peer reviewed journals. Were things a bit messy? Yes! Its a pandemic, things didn't go perfectly. But is there any scientifically based reason to believe that the vaccine is not safe and effective against death? Their studies categorically proved that.
  • phatfish 6y ago
    It's not a hit piece. There was a mistake during the trial with dosage, and instead of coming clean in their main announcement and explaining what happened it was obfuscated by the "half dose" story. This just caused confusion and provided ammunition for critics. It's great the vaccine is as effective and safe as predicted, but fumbling the most important clinical trial in the companies history reflected very poorly on their competence.
  • alistairSH 6y ago
    Uh, they completely botched the dosing in during the trial. Not just a little, but off by 50%. Then results weren't as expected (those on lower dose fared better) and they had no explanation. That's not a "full trial which proved safety and efficacy".